ExploreWatchlistsPricing
  1. JP-listed companies
  2. SYSMEX CORPORATION
  3. Financials
  4. Gross margin (%)

SYSMEX CORPORATION (6869)

Market cap
¥838.2B
P/E ratio
20.2x
Develops and manufactures medical testing equipment and reagents for blood tests and urinalysis, serving healthcare institutions worldwide.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndGross margin (%) YoY (%)
Mar 31, 202553.5+1.76%
Mar 31, 202452.5-0.18%
Mar 31, 202352.6+0.47%
Mar 31, 202252.4+3.58%
Mar 31, 202150.6-4.42%
Mar 31, 202052.9-3.89%
Mar 31, 201955.1+100.71%
Mar 31, 201827.4-10.32%
Mar 31, 201730.6-48.75%
Mar 31, 201659.7+4.85%
Mar 31, 201556.9

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat